Teva Pharmaceutical

The worst seems over for Teva
The worst seems over for Teva
GoinPharma
Teva Pharmaceutical
Ajovy
migraines
Flag link:
Teva wins much-needed US approval of migraine drug
Teva wins much-needed US approval of migraine drug
Biopharma Dive
Ajovy
Teva Pharmaceutical
migraines
Flag link:
Teva Is Said to Draw Interest From Recipharm, EMS for Medis Unit
Teva Is Said to Draw Interest From Recipharm, EMS for Medis Unit
Bloomberg
Teva Pharmaceutical
Medis
EMS
Recipharm
M&A
Flag link:
Teva holding off launch of opioid addiction drug
Teva holding off launch of opioid addiction drug
Pharmaforum
Teva Pharmaceutical
opioids
opioid addiction
generics
Dr Reddy's
Suboxone
Indivior
Flag link:
Teva wins FDA nod for sublingual film to treat opioid dependence
Teva wins FDA nod for sublingual film to treat opioid dependence
Drug Delivery Business News
Teva Pharmaceutical
FDA
opioids
opioid addiction
Cassipa
sublingual treatments
Flag link:
Once a blockbuster-to-be, Teva finally sounds taps for its PhIII loser laquinimod
Once a blockbuster-to-be, Teva finally sounds taps for its PhIII loser laquinimod
Endpoints
Teva Pharmaceutical
laquinimod
Flag link:
Attention Biotech Investors: Mark Your Calendar For These September PDUFA Dates
Attention Biotech Investors: Mark Your Calendar For These September PDUFA Dates
Yahoo/Benzinga
biotech
FDA
Roche
Tecentriq
GSK
mepolizumab
Teva Pharmaceutical
fremanezumab
Adamis Pharmaceuticals
Symjepi
Insmed
ALIS
Antares
XYOSTED
Eli Lilly
galcanezumab
Pfizer
dacomitinib
Flag link:
Biogen, Teva benefit as payers ease up on multiple sclerosis meddling: analyst
Biogen, Teva benefit as payers ease up on multiple sclerosis meddling: analyst
Fierce Pharma
Biogen
Teva Pharmaceutical
MS
multiple sclerosis
payers
Flag link:
FDA Approves New Generic Version Of The EpiPen For Allergic Reactions
FDA Approves New Generic Version Of The EpiPen For Allergic Reactions
NPR
EpiPens
generics
Teva Pharmaceutical
Mylan
allergic reaction
Flag link:
Teva scoffs at whistleblowers' evidence in bid to dismiss kickbacks case
Teva scoffs at whistleblowers' evidence in bid to dismiss kickbacks case
Fierce Pharma
Teva Pharmaceutical
Copaxone
Azilect
kickbacks
generics
whistleblowers
Flag link:
Teva and Regeneron's Fasinumab Meets Primary and Secondary Endpoints in Patients with Chronic Pain from Osteoarthritis of the Knee or Hip
Teva and Regeneron's Fasinumab Meets Primary and Secondary Endpoints in Patients with Chronic Pain from Osteoarthritis of the Knee or Hip
CP Wire
Teva Pharmaceutical
Regeneron
fasinumab
osteoarthritis
Flag link:
Teva and Regeneron's Fasinumab Meets Primary and Secondary Endpoints in Patients with Chronic Pain from Osteoarthritis of the Knee or Hip
Teva Pharmaceutical
Regeneron
fasinumab
osteoarthritis
Flag link:
Teva confident migraine drug will launch this year despite new manufacturing woes
Teva confident migraine drug will launch this year despite new manufacturing woes
Biopharma Dive
Teva Pharmaceutical
fremanezumab
migraines
Flag link:
Teva’s Granix Gets FDA Approval for Expanded Indication
Teva’s Granix Gets FDA Approval for Expanded Indication
Market Realist
Teva Pharmaceutical
Granix
pediatric
neutropenia
Flag link:
Teva stock drops 4.5% in spite of Q2 profit beat, revenue match
Teva stock drops 4.5% in spite of Q2 profit beat, revenue match
Marketwatch
Teva Pharmaceutical
earnings
Copaxone
Flag link:
Teva’s one-time blockbuster-to-be — and now recurring embarrassment — laquinimod fails yet again, this time for Huntington’s
Teva’s one-time blockbuster-to-be — and now recurring embarrassment — laquinimod fails yet again, this time for Huntington’s
Endpoints
Teva Pharmaceutical
Active Biotech
Huntington's disease
clinical trials
laquinimod
Flag link:
A Look at Teva’s Earnings Estimates ahead of Q2 Results
A Look at Teva’s Earnings Estimates ahead of Q2 Results
Market Realist
Teva Pharmaceutical
earnings
Copaxone
Flag link:
Teva, lured by $40M tax break, packs its bags for New Jersey HQ move
Teva, lured by $40M tax break, packs its bags for New Jersey HQ move
Fierce Pharma
Teva Pharmaceutical
New Jersey
headquarters
Flag link:
Teva implements impressive recovery strategy
Teva implements impressive recovery strategy
GoinPharma
Teva Pharmaceutical
Kåre Schultz
restructuring
Flag link:
Teva to Discontinue Trial of Fremanezumab in Chronic Cluster Headache
Teva to Discontinue Trial of Fremanezumab in Chronic Cluster Headache
CP Wire
Teva Pharmaceutical
fremanezumab
cluster headaches
migraines
Flag link:

Pages